ESC Premium Access

Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification

Congress Presentation

About the speaker

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

8 more presentations in this session

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation: a propensity-weighted cohort study

Speaker: Associate Professor E. Grove (Aarhus, DK)


Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry

Speaker: Ms K. Pieper (London, GB)


Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF

Speaker: Professor G. Lip (Liverpool, GB)


Impact of age > 75 years on one-year events in patients with atrial fibrillation and left atrial appendage occluder implantation. Results of the prospective LAARGE Registry

Speaker: Professor U. Zeymer (Ludwigshafen, DE)


Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)


Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention - General

Speakers: Doctor A. Bisson, Associate Professor E. Grove, Ms K. Pieper, Professor G. Lip, Professor U. Zeymer...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb